Clinical trial · Interventional
Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
NCT02517281CI-TRIAL-00122777SKINTARGETcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to do a descriptive analysis of the cutaneous toxicity observed in patients treated using targeted therapies in order to have a better understanding of the skin pathophysiology.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patients having received targeted therapies
- description
- Patients treated using targeted therapies
- interventionNames
- Procedure: Biopsy
Primary outcomes (1)
- measure
- Number of clinical secondary effects bind to targeted therapies
- timeFrame
- Every 28 days up to 5 years
- description
- Dermatological exam including questionnaire, clinical examination and photographies
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with cancer beginning a targeted therapy * Patients able to follow the protocol * Age \>/= 18 years old * Signed inform consent Exclusion Criteria: * Patient unable to follow the protocol, having a non cooperative behavior or unable to come to follow up visits or unable to complete the study * Pregnant or breastfeeding woman
References
Publications (1)
- RESULTCharles C, Razavi D, Bungener C, Mateus C, Lanoy E, Verschoore M, Dauchy S, Robert C. Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study. Clin Drug Investig. 2016 Mar;36(3):235-42. doi: 10.1007/s40261-015-0373-8. PMID 26754775